-
digital.ahrq.gov/principal-investigator/manning-john-d
January 01, 2024 - emergency medical services providers, reducing the time between first medical contact and reperfusion therapy
-
digital.ahrq.gov/principal-investigator/stopyra-jason-p
January 01, 2024 - emergency medical services providers, reducing the time between first medical contact and reperfusion therapy
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015135-arora-final-report-2008.pdf
January 01, 2008 - cure rates are 45%-70% with the use of injection therapy for a 6-18 month period and
the intensive … The only current treatment (drug therapy with
Interferon and Ribavirin) of Hepatitis C involves severe … The purpose of the study was
to show that Hepatitis C treatment through ECHO is as safe as therapy given … Because therapy is discontinued at 12 weeks in
non-responders, SAE and treatment completion rates were … Virological
response and safety outcomes in therapy-naive patients
treated for chronic hepatitis C
-
digital.ahrq.gov/ahrq-funded-projects/telehealth-education-asthma-connecting-hospital-and-home-teachh
August 31, 2024 - Guideline-recommended daily controller therapy can reduce the likelihood of severe exacerbations in children … with persistent asthma, but nonadherence to this therapy is common. … both inpatient and outpatient settings result in missed opportunities to address suboptimal asthma treatment
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/chan-d-et-al-2003
January 01, 2003 - Adherence measures were assessed by therapeutic and diagnostic monitoring. … Therapeutic monitoring included digital videos of patients using their controller medication inhaler. … Disease control was assessed by examining quality of life, utilization of services, rescue-therapy use … Rescue therapy was infrequent. A high rate of satisfaction with home telemonitoring was reported.
-
digital.ahrq.gov/sites/default/files/docs/citation/implementation-guide.pdf
December 01, 2018 - Charlie decides to recommend
physical therapy to Mr. … report to determine what care gaps exist (e.g., overdue for Urine Drug
Screening, no non-pharmacologic therapies … Intervention “Non-opioid
medications”
Medications with analgesic effects which may provide therapeutic … Intervention “Non-
pharmacologic
treatments”
Non-medication procedures and therapies employed to treat … pain (e.g., physical
therapy, massage, yoga).
-
digital.ahrq.gov/organization/wake-forest-university-health-sciences
January 01, 2023 - emergency medical services providers, reducing the time between first medical contact and reperfusion therapy
-
digital.ahrq.gov/location/usa-nc-winston-salem
January 01, 2023 - emergency medical services providers, reducing the time between first medical contact and reperfusion therapy
-
digital.ahrq.gov/ahrq-funded-projects/multi-site-trial-test-benefits-adding-personalized-risk-calculator-online
July 31, 2025 - This mechanical pump is now rivaling heart transplant as the standard treatment of advanced heart failure … This new tool will offer patients a better understanding of how treatment options align with their values … dynamic nature of patient needs and ensure that patients with advanced heart failure receive tailored treatments … Integrating personalized risk scores in decision making about left ventricular assist device (LVAD) therapy … Integrating personalized risk scores in decision making about left ventricular assist device (LVAD) therapy
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017150-lapane-final-report-2010.pdf
January 01, 2010 - Physicians overrode alerts often, and this did not vary by treatment arm. … Drug
therapy is the primary approach to managing chronic disease in older adults. … Polypharmacy may
be the new paradigm for quality drug therapy in the elderly.3 Over 85% of adults 65 … We observed no differences by treatment arm
in the physician survey data. … A new paradigm for
quality drug therapy in the elderly.
-
digital.ahrq.gov/document-type/publication
January 01, 2023 - Alcantara, Carmela
Project Name
Using eHealth to Expand Access to Cognitive Behavioral Therapy
-
digital.ahrq.gov/care-setting/ambulance
January 01, 2023 - emergency medical services providers, reducing the time between first medical contact and reperfusion therapy
-
digital.ahrq.gov/ahrq-funded-projects/myhealthportal-using-electronic-portal-empower-patients-breast-cancer
January 01, 2023 - patient portal, called "MyHealthPortal," that integrates PHRs with educational and support content about treatment … were as follows:
Develop a patient-centered web-based portal for breast cancer patients undergoing treatment … Disclaimer details
Close
Patient experience of taking adjuvant endocrine therapy … Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow.
-
digital.ahrq.gov/ahrq-funded-projects/improving-adherence-and-outcomes-artificial-intelligence-adapted-text-messages
January 01, 2023 - reasons for not taking their medication as prescribed, such as beliefs about their disease and its treatment … webinar addressed the potential of health IT to improve medication monitoring, adherence, and medication therapy … and recommendations for clinical decision support used by community pharmacists delivering medication therapy
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017075-sequist-final-report-2010.pdf
January 01, 2010 - primary outcomes measures included performance of an electrocardiogram and administration of
aspirin therapy … Among high risk patients, women were much less likely than men to receive aspirin therapy (OR
0.67, … Older age was associated with
higher rates of aspirin therapy (OR 1.2 (per decade), p = 0.02). … Among low risk patients, older age was associated with higher rates of aspirin therapy
(OR 1.9, p < … Female patients were less likely than male patients to
receive aspirin therapy (OR 0.44, p < 0.01),
-
digital.ahrq.gov/sites/default/files/docs/cds-medication-management-slides-012814.pdf
January 28, 2014 - the Speakers’
Bureau for several commercial entities and has received research support from Corcept Therapeutics … Diagnostics,
Roche Products Ltd., SHIRE Development, Sunovion, and Takeda
Research Support
Corcept Therapeutics … ECT=electroconvulsive therapy.
American Psychiatric Association. … Psychotherapy Other
Antidepressants Cognitive behavioral therapy ECT
Interpersonal therapy Phototherapy … New York, NY: John Wiley and Sons; 1999
Depression Algorithm
• Need to incorporate new treatments
-
digital.ahrq.gov/ahrq-funded-projects/medication-safety-primary-care-practice-translating-research-practice
January 01, 2023 - process produced medication safety measures in five categories: avoiding potentially inappropriate therapy … intervention, practice performance improved significantly on avoidance of potentially inappropriate therapy
-
digital.ahrq.gov/organization/university-south-florida
January 01, 2023 - effectiveness, feasibility, and acceptability of an established computer-assisted cognitive behavioral therapy
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017160-kmetik-final-report-2009.pdf
January 01, 2009 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical … of these categories are noted in the measures (eg, patient exception because of
patient refusal of treatment … • CAD: Drug Therapy for Lowering LDL-Cholesterol
• CAD: Beta-blocker Therapy – Prior Myocardial … Infarction
• CAD: ACE Inhibitor/ARB Therapy
• HF: Beta-blocker Therapy
• HF: ACE Inhibitor/ARB … Therapy
• HF: Warfarin Therapy for Patients with Atrial Fibrillation
Detailed specifications for
-
digital.ahrq.gov/sites/default/files/docs/page/2006Cullen_051111comp.pdf
June 16, 2021 - Received 17 73.9%
Female 7 28.0% PPD+ 2 11.7%
Age: <15 yrs
15-44 yrs
3
17
12.0%
68.0%
w/ Treatment … 83.3%
17.7%
Pap Smear 5 100.0%
# w/ RPR (Syphilis Test)
(in the last 12 months) 14 56.0%
TREATMENT … )
# %
Reactive
Non-Reactive
1
10
7.1%
71.4%
ARV Therapy given
HAART
21
14
84.0%
66.7% … Refused
NMI
0
0
0.0%
0.0%
Mono Therapy
Other Combination
2
5
9.5%
23.8%
Undetermined